SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002571
Filing Date
2020-04-24
Accepted
2020-04-24 16:15:48
Documents
8
Period of Report
2020-06-08
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241441zdef14a.htm DEF 14A 738143
2 G343783.JPG g343783.jpg GRAPHIC 14486
3 G182221.JPG g182221.jpg GRAPHIC 68799
4 G98118.JPG g98118.jpg GRAPHIC 72782
5 G512496.JPG g512496.jpg GRAPHIC 38026
6 G511219.JPG g511219.jpg GRAPHIC 27098
7 G20292BMI001.GIF g20292bmi001.gif GRAPHIC 83715
8 G20292BMI002.GIF g20292bmi002.gif GRAPHIC 60288
  Complete submission text file 0001047469-20-002571.txt   1243292
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35060 | Film No.: 20815134
SIC: 2834 Pharmaceutical Preparations